GERALD LEWIS: Open Payments
NPI 1639279177 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77,374 in 291 payments from 24 companies in 2025. Trend: 2023 $100,882 · 2024 $84,279 · 2025 $77,374
Speaker / faculty: $50,216Honoraria: $12,352Food & beverage: $6,366Consulting: $6,000Travel & lodging: $2,433Education: $8
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 53 | $38,010 |
| Otsuka America Pharmaceutical, Inc. | 36 | $16,906 |
| Axsome Therapeutics, Inc. | 31 | $14,668 |
| ABBVIE INC. | 31 | $4,950 |
| Vanda Pharmaceuticals Inc. | 12 | $378 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $341 |
| Supernus Pharmaceuticals, Inc. | 25 | $268 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $244 |
| Corium, LLC | 10 | $187 |
| Janssen Pharmaceuticals, Inc | 8 | $184 |
Products named: INGREZZA, Auvelity, ABILIFY MAINTENA, REXULTI, VRAYLAR, FANAPT, CAPLYTA, Qelbree.
Industry payments across IN — which companies pay providers there.
